All News

Regulatory officials said additional requirements are needed in order to approve the drug, which is under review for treatment of myelofibrosis, polycythemia vera, and graft-versus-host disease.

The proposed legislation, sponsored by Chuck Grassley and Maria Cantwell, aims to necessitate transparency from PBMs.

According to a study, patients are frequently prescribed broad-spectrum antibiotics instead of narrowly tailored antibiotics, which would be more optimized to treat them.

Dupilumab met both its primary and key secondary endpoints in a phase 3 trial, demonstrating efficacy as a potential treatment for atopic hand and foot dermatitis.

The drug, called Lumisight, is an optical imaging agent that detects cancerous tissue during initial lumpectomy to allow for a more complete resection. An NDA has been submitted to the FDA.

Evkeeza, which treats a rare form of high cholesterol, is now approved for patients as young of 5 years.

Here’s a look back at the cancer drugs that gained FDA approval in the winter of 2023.

Despite telehealth’s rise in popularity during the height of COVID-19, many individuals still aren't aware that it's a viable option.

The company also will establish a $35 out-of-pocket price cap for for all patients with commercial insurance that use Latnus

There was a lower probability of initiating psycholeptics and experiencing postpartum psychiatric emergencies in study patients who continued using antidepressants

Your weekly roundup of the latest news from Drug Topics®.

Polio prevalence has been reduced by 99.99% in the past 35 years. But the disease continues to exist in countries like Pakistan and Afghanistan, where it seeds outbreaks elsewhere.

A combination of dabrafenib with trametinib was approved by the FDA for treatment of pediatric patients 1 year and older with low-grade glioma & BRAF V600E mutation who require systemic therapy.

The vaccine, developed by GSK, is "very encouraging" step in fight to treat meningococcal disease

Treating myelofibrosis with Jakafi earlier has shown promise in improving both survival and symptom burden

The combination of prednisone and methotrexate provided nearly complete or complete hair regrowth in up to 31.2% of patients with alopecia areata.

Drug Topics will continue to update this story as new information becomes available.

A new booster shot of the Pfizer-BioNTech COVID-19 vaccine is now available for children aged 6 months to 4 years, in an effort to continue to curb the effects of COVID-19

Results from a phase 3 study show that the drug is effective in treating VMS symptoms due to menopause.

Per VA regulations, anyone who has had a stroke or seizure within the last year, as well as those with MRIs showing microhemmorrhages, aneurysms, lesions or tumors would be excluded from coverage of the drug, called Leqambi

How are hiring trends shaping up for the future of health care?

The product, called Lenire, uses bimodal stimulation and will be available in April 2023

According to a company press release, the price reductions will go into effect at the start of 2024

The President said he will make Medicare “solvent beyond 2050 without cutting a penny in benefits.”

The spray, called Zavzpret, intends to help individuals who struggle with migraines but can't take oral medication because of nausea or vomiting

Critics of PBM's say that the high number of exclusions narrows patient options and make medications financially inaccessible.

Your weekly roundup of the latest news from Drug Topics®.